A recent study suggests that individuals who stop using new slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end traditional lifestyle regimens.
Findings released in a prominent health publication shows that while obese individuals frequently drop a large proportion of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Users using such drugs need to be cognizant of the potential of fast rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain means a reversion to starting mass in about a year and a half.
Comparing Treatments
The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
Scientists point out that people who shed pounds through dieting generally see a slower creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Quick Regain
Nutrition scientists propose the mode of action of the injections accounts for the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the body to produce less of its endogenous hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making overeating far more likely."
A Chronic Issue?
The NHS suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals contend that, considering the likelihood of weight regain, the treatment might need to be life-long.
This opinion is supported by drug manufacturers, who state that the findings "emphasize the persistent character of excess weight," similar to managing conditions like hypertension.
User Testimonies
Individuals who have come off the medication explain a powerful return of cravings.
"It was like a trigger flipping and you're instantly extremely hungry," described an individual.
The struggle is worsened if users have not established lasting lifestyle or habit modifications during therapy.
Widespread Interest
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Use is higher among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers caution that while GLP-1 drugs are potent tools for weight loss, they are not a magic solution and maintained weight loss likely depends on combined lifestyle changes.
